Gerry, a molecular biologist, has 25 years’ experience in the biotechnology and pharmaceutical industries, in regulatory affairs, clinical development and business roles, and as Non-Executive Director in several Biotech firms. He has worked with large and medium pharma companies (Almirall, Spain and Glaxo, UK) and at The Liposome Company, a US biotechnology firm. In 1998, he founded the European regulatory affairs and product development consultancy, GMG BioBusiness Ltd, which was sold to a top 5 CRO in 2005. In 2006 he became the first CEO of the biotechnology development agency, Biocat, in Barcelona, Spain. Thereafter he set up Kinesys Consulting Ltd, which supports the biopharma industry with Development, Regulatory and Commercial services. In 2104 he assumed the part-time role of COO at amp biosimilars, AG, Germany.
Biotechnology, Pharmaceutical sciences, Regulatory affairs